Related Experiment Video
Updated: Aug 9, 2026

Culture of myeloid dendritic cells from bone marrow precursors
Published on: July 26, 2008
Disparate functions of immature and mature human myeloid dendritic cells: implications for dendritic cell-based
Katharina Tschoep1, Thomas C Manning, Helena Harlin
1Department of Pathology, Section of Hematology/Oncology, University of Chicago, Illinois, USA. tgajewsk@medicine.bsd.uchicago.edu
Abstract:
Although antigen-loaded dendritic cells (DC) are being investigated as antitumor vaccines, which DC differentiation state is most effective is not clear. Three DC functions that may be critical for immunization potential are expression of CD80/86, cytokine production following CD40 engagement, and migration to chemokine receptor 7-binding chemokines. We therefore examined highly purified human monocyte-derived immature and mature DC for these properties from normal donors and cancer patients. Although high expression of CD80/86 and migration to 6Ckine + macrophage-inflammatory protein-3beta were properties of mature DC, cytokine production following CD40 ligation was superior by immature DC. Loss of cytokine secretion occurred with multiple maturation conditions, was not apparently reversible, and was also seen with lipopolysaccharide stimulation in correlation with down-regulated Toll-like receptor expression. Our results suggest that the functions thought to contribute to optimal T cell priming are not coexpressed by the same DC population and that immature and mature DC likely possess distinct CD40-mediated signaling events.
Related Concept Videos
Cell-mediated Immune Responses
Vaccinations
Cells of the Adaptive Immune Response
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Vaccines

